Evidence map›Paper›PMID 25140800›Full record

ArticlePloS one2014

Photodynamic therapy using systemic administration of 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode for methicillin-resistant Staphylococcus aureus-infected ulcers in mice.

Kuniyuki Morimoto, Toshiyuki Ozawa, Kunio Awazu, Nobuhisa Ito, Norihiro Honda, Sohkichi Matsumoto, Daisuke Tsuruta

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Photodynamic disinfection and its role in controlling infectious diseases.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2021
    Review
  10. Review
  11. The Role of Porphyrinoid Photosensitizers for Skin Wound Healing.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Antibacterial photosensitization through activation of coproporphyrinogen oxidase.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kuniyuki MorimotoDepartment of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Toshiyuki OzawaDepartment of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kunio AwazuMedical Beam Physics Laboratory, Osaka University Graduate School of Engineering, Osaka, Japan.
Nobuhisa ItoMedical Beam Physics Laboratory, Osaka University Graduate School of Engineering, Osaka, Japan.
Norihiro HondaMedical Beam Physics Laboratory, Osaka University Graduate School of Engineering, Osaka, Japan.
Sohkichi MatsumotoDepartment of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Daisuke TsurutaDepartment of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Osaka City University · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial resistance to antibiotics has become a worldwide problem. One potential alternative for bacterial control is photodynamic therapy. 5-aminolevulinic acid is a natural precursor of the photosensitizer protoporphyrin IX. Relatively little is known about the antibacterial efficacy of photodynamic therapy using the systemic administration of 5-aminolevulinic acid; a few reports have shown that 5-aminolevulinic acid exerts photodynamic effects on methicillin-resistant Staphylococcus aureus (MRSA) in vitro. In this study, we evaluated the effectiveness of photodynamic therapy using 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode in vitro and in vivo for the treatment of MRSA. We found that 5-aminolevulinic acid photodynamic therapy with the light-emitting diode had an in-vitro bactericidal effect on MRSA. In vivo, protoporphyrin IX successfully accumulated in MRSA on ulcer surfaces after intraperitoneal administration of 5-aminolevulinic acid to mice. Furthermore, 5-aminolevulinic acid photodynamic therapy accelerated wound healing and decreased bacterial counts on ulcer surfaces; in contrast, vancomycin treatment did not accelerate wound healing. Our findings indicate that 5-aminolevulinic acid photodynamic therapy may be a new treatment option for MRSA-infected wounds.

Indexed as

Aminolevulinic AcidAnimalsAnti-Bacterial AgentsLightMaleMethicillin-Resistant Staphylococcus aureusMiceMice, Inbred C57BLPhotochemotherapyPhotosensitizing AgentsStaphylococcal InfectionsUlcerWound HealingAminolevulinic AcidAnti-Bacterial AgentsPhotosensitizing Agents

Identifiers

PMID25140800
PMCPMC4139315
OpenAlexW2061982698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.